Is there a link between elevated C-reactive protein levels and specific breast cancer molecular subtypes?
Main Author: | Kadri Altundag |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623007476 |
Similar Items
-
Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
by: Kadri Altundag
Published: (2023-06-01) -
S100 protein in molecular subtypes of breast cancer
by: Ecaterina Carpenco
Published: (2020-10-01) -
Serum endocan level and its prognostic significance in breast cancer patients
by: Ozturk Ates, et al.
Published: (2018-04-01) -
Evaluation of c-reactive protein in breast cancer by enzyme linked immunoassay technique
by: Ambreen Usmani, et al.
Published: (2020-11-01) -
Current and emerging treatment options in triple-negative breast cancer
by: Omer Dizdar, et al.
Published: (2011-12-01)